Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 29 (7) , 633-639
- https://doi.org/10.1016/0028-3908(90)90024-l
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Synthesis of racemic, S(+)- and R(-)-N-[methyl-3H]3,4-methylenedioxymethamphetamineJournal of Labelled Compounds and Radiopharmaceuticals, 1990
- Stereochemistry of the metabolism of MDMA to MDALife Sciences, 1989
- Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicityEuropean Journal of Pharmacology, 1988
- MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neuronsPharmacology Biochemistry and Behavior, 1988
- Aminergic systems in Alzheimer's disease and Parkinson's diseaseAnnals of Neurology, 1987
- Autoradiographic localization of 3H‐paroxetine‐labeled serotonin uptake sites in rat brainSynapse, 1987
- Characterization of [3H]paroxetine binding to rat cortical membranesEuropean Journal of Pharmacology, 1985
- Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)Journal of Pharmaceutical Sciences, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: Correlations with serotonin levels and histochemical fluorescenceBrain Research, 1972